If we fail to scale manufacturing in the United States, then our best bio-innovations will be brewed in China.

The lawsuit, filed Monday in US District Court for Massachusetts, was co-led by Andrea Campbell and asserts that the Trump ...

Another healthcare stock came across our desk during the mid-week session after it was announced that Piper Sandler initiated ...

Though most biopharma investment is in two states, follow this model to bring the research—and investments—elsewhere.

Celia Witten, M.D., Ph.D., is no longer deputy director of the FDA’s Center for Biologics Evaluation and Research (CBER), ...

Join us for networking, mentoring, cocktails and business savvy advice being shared. What… Join the Boston Business Journal for our Business of Higher Education program… Save the date ...

According to the report, it marks the largest layoff in the history of the organization — Massachusetts’ largest private ...

Aurion Biotech, Inc. (Aurion), whose mission is to restore vision to millions of patients with life-changing regenerative ...